Literature DB >> 2881888

Mouse candidiasis. II. Host responses are T-cell dependent and regulated by genes in the major histocompatibility complex.

R B Ashman.   

Abstract

Administration of a Thy-1.2-specific monoclonal antibody to BALB/c mice resulted in a significant decrease in the efficiency of clearance of Candida albicans from the spleen. The rate of clearance of organisms from the spleen of congenic mice was determined by genes in the major histocompatibility complex, as was the magnitude of the inflammatory response in the popliteal lymph node after footpad immunization. These results formally demonstrate the involvement of T cells in host responses to primary candida infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881888     DOI: 10.1007/bf00344035

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  28 in total

1.  Evidence for macrophage-mediated protection against lethal Candida albicans infection.

Authors:  F Bistoni; A Vecchiarelli; E Cenci; P Puccetti; P Marconi; A Cassone
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

2.  Experimental murine candidiasis: pathological and immune responses in T-lymphocyte-depleted mice.

Authors:  D K Giger; J E Domer; S A Moser; J T McQuitty
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

Review 3.  Mycoses complicating AIDS.

Authors:  A Stenderup; H Schønheyder
Journal:  Microbiol Sci       Date:  1984-12

4.  Immunity to Candida albicans.

Authors:  T J Rogers; E Balish
Journal:  Microbiol Rev       Date:  1980-12

5.  Protective effect of glucan in experimentally induced candidiasis.

Authors:  D L Williams; J A Cook; E O Hoffmann; N R Di Luzio
Journal:  J Reticuloendothel Soc       Date:  1978-06

6.  Suppressor thymus-derived lymphocytes in fungal infection.

Authors:  J D Stobo; S Paul; R E Van Scoy; P E Hermans
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

7.  Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans.

Authors:  D K Giger; J E Domer; J T McQuitty
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

8.  Candidiasis in cancer patients.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

9.  Absence of correlation between delayed-type hypersensitivity and protection in experimental systemic candidiasis in immunized mice.

Authors:  B Hurtrel; P H Langrange; J C Michel
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

10.  THE ROLE OF THE THYMUS IN RESISTANCE TO INFECTION AND ENDOTOXIN TOXICITY.

Authors:  S B SALVIN; R D PETERSON; R A GOOD
Journal:  J Lab Clin Med       Date:  1965-06
View more
  11 in total

1.  Primary role for CD4(+) T lymphocytes in recovery from oropharyngeal candidiasis.

Authors:  C S Farah; S Elahi; K Drysdale; G Pang; T Gotjamanos; G J Seymour; R L Clancy; R B Ashman
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.

Authors:  Hong Xin; Jim E Cutler
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

3.  Susceptibility of beige mutant mice to candidiasis may be linked to a defect in granulocyte production by bone marrow stem cells.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

4.  Effect of Friend leukemia virus infection on susceptibility to Candida albicans.

Authors:  M A Moors; S M Jones; K K Klyczek; T J Rogers; H R Buckley; K J Blank
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  Candida arthritis: cellular immune responses of synovial fluid and peripheral blood lymphocytes to Candida albicans.

Authors:  E Hermann; W J Mayet; O Klein; A W Lohse; C Trautwein; I Michiels; T Poralla; K H Meyer zum Büschenfelde
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

6.  A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice.

Authors:  A Mencacci; A Torosantucci; R Spaccapelo; L Romani; F Bistoni; A Cassone
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome.

Authors:  S Mahanty; R A Greenfield; W A Joyce; P W Kincade
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

8.  Protection against murine disseminated candidiasis mediated by a Candida albicans-specific T-cell line.

Authors:  T G Sieck; M A Moors; H R Buckley; K J Blank
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  Major histocompatibility complex-dependent susceptibility to Cryptococcus neoformans in mice.

Authors:  Erin E McClelland; Donald L Granger; Wayne K Potts
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

Review 10.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.